Current filters:


7926 to 7935 of 98147 results

Abbott board prepares way for AbbVie split off


US health care giant Abbott Laboratories (NYSE: ABT) says that its board of directors has approved the…

Abbott LaboratoriesAbbVieFinancialPharmaceutical

First success of selumetinib, a targeted therapy in most common NSCLC


A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists…

Array BioPharmaAstraZenecaOncologyPharmaceuticalResearchselumetinib

Biosimilars threaten to burst Humira's blockbuster bubble


US health care major Abbott Laboratories' (NYSE: ABT) Humira (adalimumab) has a strong reputation as…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGenericsHumiraMarkets & Marketing

Cuba sets up pharmaceutical industry group


Cuba announced the setting up of BioCubaFarma, the Biotechnological and Pharmaceutical Industry Group,…

BiotechnologyMarkets & MarketingPharmaceuticalSouth America

Chemotherapy-induced nausea and vomiting market to reach $2.1 billion in 2018


The global chemotherapy-induced nausea and vomiting (CINV) market was worth $1.3 billion in 2011 and…

Markets & MarketingOncologyPharmaceutical

FDA panel backs accelerated approval of Janssen's bedaquiline for MDR-TB


Janssen Research & Development, a unit of US health care major Johnson & Johnson (NYSE: JNJ), says that,…

North AmericaPharmaceuticalRespiratory and Pulmonary

Express Scripts finds most used Rx drugs price hikes six times that of overall US inflation


The US Prescription Price Index shows that, since September 2011, price inflation for the most highly…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

7926 to 7935 of 98147 results

Back to top